Background
cancer, Lung cancer, cancer death
CANCER, LUNG CANCER
Lung cancer is the second most commonly diagnosed cancer worldwide but leading the cause of cancer death [Rezivertinib (BPI-7711) is a novel third-generation EGFR TKI jointly developed by Beta Pharma (Shanghai) Co., Ltd., Shanghai, People’s Republic of China, and Beta Pharma Inc., Princeton, NJ, USA, which can selectively target specific mutated 